Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-β1b)
Ferdinando Nicoletti(University of Catania), A. Reggio(University of Catania), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Paola Zaccone(University of Catania), Francesco Patti(University of Catania), Roberto Di Marco(University of Catania), Franca Stivala(University of Catania), E. Reggio(Copenhagen University Hospital), Alessandra Nicoletti(University of Catania)
Cited by 80
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508